Insider Selling: ICU Medical, Inc. (NASDAQ:ICUI) COO Sells $331,734.96 in Stock

ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander sold 1,962 shares of the firm’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Christian B. Voigtlander also recently made the following trade(s):

• On Wednesday, November 27th, Christian B. Voigtlander sold 1,430 shares of ICU Medical stock. The stock was sold at an average price of $158.00, for a total transaction of $225,940.00.

ICU Medical Stock Up 1.3 %

Shares of NASDAQ ICUI opened at $159.75 on Friday. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The company has a market cap of $3.91 billion, a P/E ratio of -34.96 and a beta of 0.66. ICU Medical, Inc. has a 52 week low of $83.26 and a 52 week high of $196.26. The business has a 50-day simple moving average of $175.28 and a two-hundred day simple moving average of $146.60.

Analysts Set New Price Targets

ICUI has been the subject of a number of analyst reports. Raymond James increased their price target on ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research report on Thursday, September 12th. KeyCorp lifted their price target on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday, November 13th. Jefferies Financial Group initiated coverage on ICU Medical in a research report on Monday, October 14th. They issued a “hold” rating and a $183.00 target price for the company. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $173.00.

Hedge Funds Weigh In On ICU Medical

Several hedge funds have recently bought and sold shares of ICUI. Innealta Capital LLC bought a new position in ICU Medical in the 2nd quarter valued at $32,000. Hexagon Capital Partners LLC boosted its stake in ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 122 shares during the period. Allworth Financial LP grew its position in ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 100 shares in the last quarter. EntryPoint Capital LLC increased its stake in ICU Medical by 731.5% in the 1st quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier’s stock worth $48,000 after acquiring an additional 395 shares during the last quarter. Finally, Russell Investments Group Ltd. raised its holdings in shares of ICU Medical by 46.4% in the 1st quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock valued at $59,000 after acquiring an additional 173 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.